bullish
Wuxi Biologics Placement - This Time It's Different
456 Views29 Jun 2020 18:42
Wuxi Biologics (Cayman) Inc (2269 HK) is looking to raise around US$660m in a primary placement. This is in contrast to the nine other placement...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- HSCEI Index Rebalance - Huge Turnover as WVRs & Secondary Listings Make Their Index Debut15 Aug 2020
- Hang Seng Index Rebalance - Big Turnover, Big Impact, Some Surprises and More Changes to Come15 Aug 2020
- Wuxi Biologics - Recap/Learnings from past Placements16 Jul 2020
- Wuxi Biologics Placement - Biggest Deal Size at Launch, Well Ahead of Lock-Up Expiry20 May 2020
- Wuxi Biologics Placement: Another Pre-Lockup Placement but Past Deals Have Done Well31 Mar 2020
x